BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157, Semaglutide, And Wellness Peptides: What's Actually Allowed In California? Holt Law BPC 157: Experimental Peptide Creates Risk for Athletes The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York